These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 36070806)

  • 1. A 21L/BA.2-21K/BA.1 "MixOmicron" SARS-CoV-2 hybrid undetected by qPCR that screen for variant in routine diagnosis.
    Colson P; Delerce J; Marion-Paris E; Lagier JC; Levasseur A; Fournier PE; La Scola B; Raoult D
    Infect Genet Evol; 2022 Nov; 105():105360. PubMed ID: 36070806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First cases of infection with the 21L/BA.2 Omicron variant in Marseille, France.
    Colson P; Delerce J; Beye M; Levasseur A; Boschi C; Houhamdi L; Tissot-Dupont H; Yahi N; Million M; La Scola B; Fantini J; Raoult D; Fournier PE
    J Med Virol; 2022 Jul; 94(7):3421-3430. PubMed ID: 35243660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2 Co-Infections and Recombinations Identified by Long-Read Single-Molecule Real-Time Sequencing.
    Trémeaux P; Latour J; Ranger N; Ferrer V; Harter A; Carcenac R; Boyer P; Demmou S; Nicot F; Raymond S; Izopet J
    Microbiol Spectr; 2023 Aug; 11(4):e0049323. PubMed ID: 37260377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Culture and identification of a "Deltamicron" SARS-CoV-2 in a three cases cluster in southern France.
    Colson P; Fournier PE; Delerce J; Million M; Bedotto M; Houhamdi L; Yahi N; Bayette J; Levasseur A; Fantini J; Raoult D; La Scola B
    J Med Virol; 2022 Aug; 94(8):3739-3749. PubMed ID: 35467028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In silico evaluation of the impact of Omicron variant of concern sublineage BA.4 and BA.5 on the sensitivity of RT-qPCR assays for SARS-CoV-2 detection using whole genome sequencing.
    Sharma D; Notarte KI; Fernandez RA; Lippi G; Gromiha MM; Henry BM
    J Med Virol; 2023 Jan; 95(1):e28241. PubMed ID: 36263448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simple Wastewater Preparation Protocol Applied to Monitor the Emergence of the Omicron 21L/BA.2 Variant by Genome Sequencing.
    Wurtz N; Boussier M; Souville L; Penant G; Lacoste A; Colson P; La Scola B; Aherfi S
    Viruses; 2023 Jan; 15(2):. PubMed ID: 36851484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular evolution of SARS-CoV-2 from December 2019 to August 2022.
    Wolf JM; Wolf LM; Bello GL; Maccari JG; Nasi LA
    J Med Virol; 2023 Jan; 95(1):e28366. PubMed ID: 36458547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unraveling the Dynamics of Omicron (BA.1, BA.2, and BA.5) Waves and Emergence of the Deltacton Variant: Genomic Epidemiology of the SARS-CoV-2 Epidemic in Cyprus (Oct 2021-Oct 2022).
    Chrysostomou AC; Vrancken B; Haralambous C; Alexandrou M; Gregoriou I; Ioannides M; Ioannou C; Kalakouta O; Karagiannis C; Marcou M; Masia C; Mendris M; Papastergiou P; Patsalis PC; Pieridou D; Shammas C; Stylianou DC; Zinieri B; Lemey P; The Comessar Network ; Kostrikis LG
    Viruses; 2023 Sep; 15(9):. PubMed ID: 37766339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection and prevalence of SARS-CoV-2 co-infections during the Omicron variant circulation in France.
    Bal A; Simon B; Destras G; Chalvignac R; Semanas Q; Oblette A; Quéromès G; Fanget R; Regue H; Morfin F; Valette M; Lina B; Josset L
    Nat Commun; 2022 Oct; 13(1):6316. PubMed ID: 36274062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of SARS-CoV-2 recombinants and emerging Omicron sublineages.
    Wang Y; Long Y; Wang F; Li C; Liu W
    Int J Med Sci; 2023; 20(1):151-162. PubMed ID: 36619228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential linear B-cells epitope change to a helix structure in the spike of Omicron 21L or BA.2 predicts increased SARS-CoV-2 antibodies evasion.
    Al-Zyoud W; Haddad H
    Virology; 2022 Aug; 573():84-95. PubMed ID: 35732100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First Detection of the SARS-CoV-2 Omicron BA.5/22B in Monaco.
    Colson P; Lavagna C; Delerce J; Groshenry G; Yahi N; Fantini J; La Scola B; Althaus T
    Microorganisms; 2022 Sep; 10(10):. PubMed ID: 36296228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surveillance of SARS-CoV-2 Genetic Variants in the Polish Armed Forces Using Whole Genome Sequencing Analysis.
    Skuza K; Rutyna P; Krzowski L; Rabalski L; Lepionka T
    Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-CoV-2 Recombination and Coinfection Events Identified in Clinical Samples in Russia.
    Chernyaeva EN; Ayginin AA; Kosenkov AV; Romanova SV; Tsypkina AV; Luparev AR; Stetsenko IF; Gnusareva NI; Matsvay AD; Savochkina YA; Shipulin GA
    Viruses; 2023 Jul; 15(8):. PubMed ID: 37632003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analyzing and Modeling the Spread of SARS-CoV-2 Omicron Lineages BA.1 and BA.2, France, September 2021-February 2022.
    Sofonea MT; Roquebert B; Foulongne V; Morquin D; Verdurme L; Trombert-Paolantoni S; Roussel M; Bonetti JC; Zerah J; Haim-Boukobza S; Alizon S
    Emerg Infect Dis; 2022 Jul; 28(7):1355-1365. PubMed ID: 35642476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low SARS-CoV-2 viral load among vaccinated individuals infected with Delta B.1.617.2 and Omicron BA.1.1.529 but not with Omicron BA.1.1 and BA.2 variants.
    Selvavinayagam ST; Yong YK; Joseph N; Hemashree K; Tan HY; Zhang Y; Rajeshkumar M; Kumaresan A; Kalpana R; Kalaivani V; Monika AVD; Suvaithenamudhan S; Kannan M; Murugesan A; Narayanasamy K; Palani S; Larsson M; Shankar EM; Raju S
    Front Public Health; 2022; 10():1018399. PubMed ID: 36211690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unique mutations in SARS-CoV-2 Omicron subvariants' non-spike proteins: Potential impacts on viral pathogenesis and host immune evasion.
    Hossain A; Akter S; Rashid AA; Khair S; Alam ASMRU
    Microb Pathog; 2022 Sep; 170():105699. PubMed ID: 35944840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for SARS-CoV-2 Delta and Omicron co-infections and recombination.
    Bolze A; Basler T; White S; Dei Rossi A; Wyman D; Dai H; Roychoudhury P; Greninger AL; Hayashibara K; Beatty M; Shah S; Stous S; McCrone JT; Kil E; Cassens T; Tsan K; Nguyen J; Ramirez J; Carter S; Cirulli ET; Schiabor Barrett K; Washington NL; Belda-Ferre P; Jacobs S; Sandoval E; Becker D; Lu JT; Isaksson M; Lee W; Luo S
    Med; 2022 Dec; 3(12):848-859.e4. PubMed ID: 36332633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Baseline Sequencing Surveillance of Public Clinical Testing, Hospitals, and Community Wastewater Reveals Rapid Emergence of SARS-CoV-2 Omicron Variant of Concern in Arizona, USA.
    Smith MF; Holland SC; Lee MB; Hu JC; Pham NC; Sullins RA; Holland LA; Mu T; Thomas AW; Fitch R; Driver EM; Halden RU; Villegas-Gold M; Sanders S; Krauss JL; Nordstrom L; Mulrow M; White M; Murugan V; Lim ES
    mBio; 2023 Feb; 14(1):e0310122. PubMed ID: 36622143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2 Variability in Patients and Wastewaters-Potential Immuno-Modulation during the Shift from Delta to Omicron.
    Chaqroun A; Hartard C; Josse T; Taverniers A; Jeulin H; Gantzer C; Murray JM; Obepine Consortium ; Bertrand I; Schvoerer E
    Biomedicines; 2022 Aug; 10(9):. PubMed ID: 36140181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.